Biotechblog

New patent for Gilead Sciences drug SUNLENCA

April 25, 2024 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…
Source

New patent for Alkermes Inc drug LYBALVI

April 25, 2024 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for LYBALVI Lybalvi is a drug marketed by Alkermes Inc and is included in one NDA. It is available from one supplier. There are twelve patents…
Source

1
2
3
…
4,011
Next →